article thumbnail

CDSCO releases regulatory guidelines for sampling of drugs, cosmetics and medical devices

AuroBlog - Aurous Healthcare Clinical Trials blog

In its efforts to streamline and rationalise the sampling procedure and maintain a centralised monthly database the Central Drugs Standard Control Organisation (CDSCO) has released the final version of the regulatory guidelines for sampling of drugs, cosmetics and medical devices by drugs inspectors of the Central and State drug authorities.

Cosmetics 191
article thumbnail

Jan Vishwas Act amendment on Drugs & Cosmetics Act to be in force from December

AuroBlog - Aurous Healthcare Clinical Trials blog

The amended provisions under the Jan Vishwas (Amendment of Provisions) Act, 2023 notified by the Central government last year for removal of stringent punishments such as imprisonment from some of the Sections of the Drugs and Cosmetics Act, 1940, will be in force from December 31, 2024.

Cosmetics 152
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Industry concerned over lack of discussion on proposed New Drugs, Medical Devices & Cosmetics Bill

AuroBlog - Aurous Healthcare Clinical Trials blog

Even as the Centre has listed the New Drugs, Medical Devices and Cosmetics Bill, 2023 to be tabled in Parliament during the current session, industry members are apprehensive that the new bill may mean centralisation of licensing and other powers to the Central drug regulatory authority and it may also have provisions which may harm […]

Cosmetics 161
article thumbnail

Ten organisations including medical devices industry demand recall of New Drugs, Medical Devices & Cosmetics Bill

AuroBlog - Aurous Healthcare Clinical Trials blog

Ten collective stakeholders of Indian healthcare industry, including the industry associations of medical devices manufacturers, patient interest group, and healthcare providers, have jointly demanded to the Union health minister Dr Mansukh Mandaviya to recall the New Drugs, Medical Devices & Cosmetics Bill, 2023 that is listed to be tabled in (..)

Cosmetics 147
article thumbnail

Accelerating Consumer Product Research with Unified Clinical Trial Management Solutions

Cloudbyz

The pursuit for the most effective and safe products requires rigorous clinical research, which involves meticulous trial design, recruitment, data collection, and subsequent analysis. A delay in trials or approval can significantly impact the product’s success and the company’s bottom line.

article thumbnail

Leveraging AI-Enabled Data Extraction to Accelerate Case Processing in Clinical Trials

Cloudbyz

AI-enabled data extraction holds immense promise in expediting case processing within clinical trials, offering a transformative approach to streamline workflows and enhance efficiency. In this blog, we delve into the potential of AI in pharmacovigilance and its implications for clinical trial safety monitoring.

article thumbnail

25 Reasons Why Pharmaceutical Companies Need a Unified Clinical Trial Management Platform

Cloudbyz

Clinical trials are the backbone of drug development, and managing these trials efficiently is paramount. In recent years, the need for a unified clinical trial management platform has become increasingly evident. Document Management: Stores and manages trial-related documents in a centralized repository.